Xibin Zhuang

Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways

Daxuan Wang, Yujiao Zou, Xibin Zhuang et al. · Acta Pharmacologica Sinica · 2016 · 98 citations · Full text

Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of <i>EGFR</i>, <i>ALK</i>, <i>ROS1</i>, <i>KRAS</i> or <i>BRAF</i>

Xibin Zhuang, Chao Zhao, Jiayu Li et al. · Cancer Medicine · 2019 · 76 citations · Full text

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

Hua Zhong, Shengjie Sun, Jianhua Chen et al. · The Lancet Respiratory Medicine · 2024 · 47 citations

First-line Penpulimab, Placebo-controlled Phase 3, Medicine +8

Delayed discharge is associated with higher complement C3 levels and a longer nucleic acid-negative conversion time in patients with COVID-19

Peihuang Lin, Wenhuang Chen, Hongbo Huang et al. · Scientific Reports · 2021 · 24 citations · Full text

Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma

Hong Huang, Daxuan Wang, Weifeng Guo et al. · Pathology - Research and Practice · 2019 · 23 citations

Tumor Biology, Oncology, Medicine +13